Patent details

EP1539144 Title: MULTISTAGE FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE

Basic Information

Publication number:
EP1539144
PCT Application Number:
PCT/US/2003/029292
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037546892
PCT Publication Number:
WO/2004/026241
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MULTISTAGE FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
French Title of Invention:
NOUVELLE PREPARATION PHARMACEUTIQUE CONTENANT UN BIGUANIDE ET UN DERIVE DE LA THIAZOLIDINEDIONE
German Title of Invention:
MEHRSTUFIGE FORMULIERUNG MIT EINEM BIGUANID UND EINEM THIAZOLIDINDION-DERIVAT
SPC Number:

Dates

Filing date:
19/09/2003
Grant date:
24/12/2014
EP Publication Date:
24/12/2014
PCT Publication Date:
01/04/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/06/2005
EP B1 Publication Date:
24/12/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/09/2015
Expiration date:
19/09/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/09/2003
 
 

Name:
Andrx Labs LLC
Address:
4955 Orange Drive, Davie, FL 33314, United States (US)

Inventor

1

Name:
CARDINAL John
Address:
United States (US)

2

Name:
LODIN Unchalee
Address:
United States (US)

3

Name:
NANGIA Avinash
Address:
United States (US)

4

Name:
GOLDFARB Robert, I.
Address:
United States (US)

Priority

1

Priority Number:
412180 P
Priority Date:
27/01/2002
Priority Country:
United States (US)

2

Priority Number:
412181 P
Priority Date:
20/09/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages